Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

86
4.8.2 Nanotechnology andBiomedical Applications
Thus, inulin and its derivatives are useful in nanotechnology and biomedicine
because of their compatibility, nontoxicity, and multifunctionality. In nanotechnol-
ogy inulin is used to form the nanoparticles that are then used required to convey the
drugs involved in treatment, making the treatment operations more precise (Sharma
and Tailang 2020). These inulin-based nanoparticles can effectively encapsulate
number of drugs including anticancer agents and show improved solubility, stabil-
ity, and sustained release proles of the drugs (Peanparkdee and Iwamoto 2022). In
addition, inulin being capable of preparing hydrogels and nanocomposites renders
it possible in tissue engineering joined with regenerative medicine as inulin is sup-
portive of cell growth and tissue remodeling (Ferreira-Lazarte etal. 2020). The
functional properties of inulin are also being investigated for the new and innovative
applications such as biosensors in diagnosing certain diseases so that it could bind
with high sensitivity and specicity to specic biomolecules (Ramasamy et al.
2021; Lanjhiyana 2020). Such improvements demonstrate the use of inulin-based
nanotechnology in the biomedical area that will create new horizons in diagnostic,
therapeutic, and also tissue engineering uses.
4.8.3 Sustainability andGreen Processing
Thus, the introduction of inulin-based sustainability and green processing mar-
kets brings innovation in developing environment-friendly and effective
approaches to processing. The process of extracting inulin from sources like
chicory root has undergone enhancement so that the utilization of water and
energy is minimal and that the waste can be recycled into energy (Ramasamy
etal. 2020). It has been proven that newly developed technologies, such as ultra-
sonic and enzymatic methods, enable higher yields and faster processes, which
in turn enhance the sustainability of inulin extraction (Pankaj et al. 2015).
Moreover, inulin’s biodegradability and nontoxic nature make it an excellent
candidate for developing sustainable packaging materials and bioplastics, reduc-
ing reliance on petroleum-based plastics and decreasing plastic pollution (Sharma
2023). The integration of inulin into green processing not only supports a circu-
lar economy but also aligns with global efforts to mitigate climate change and
promote environmental stewardship (Zhang et al. 2021b; Morin-Crini et al.
2021). These advancements underscore the role of inulin in fostering sustainable
practices across various industries. Because inulin may replace substances high
in fat and sugar, it is frequently employed in the food industry. Unfortunately,
because of the numerous impurities produced by applying high temperatures, the
present commercial recovery procedure of this molecule is mostly carried out by
diffusion in hot water (70–80°C), followed by a somewhat difcult purifying
process. Food scientists have created new methods in complete accordance with
the green extraction idea based on the use of nonconventional technologies (i.e.,
pulsed electric elds, ultrasounds, microwaves, etc.) in response to the demand
B. S. R. Desu et al.

87
for more environmentally friendly, economically viable, and sustainable proce-
dures (Celińska etal. 2021).
4.9 Conclusion
Inulin has emerged as a versatile stabilizer with signicant applications across the
food, pharmaceutical, and cosmetic industries. Key ndings highlight its efcacy in
improving texture, stability, and bioavailability of various products due to its unique
physicochemical properties, including emulsication, gelation, and moisture reten-
tion. Adding it to culinary recipes can effectively stabilize the product by changing
its texture, enhancing its organoleptic properties, and extending its shelf life. Due to
its distinct structure consisting of β-(2→1) fructans, inulin has excellent emulsica-
tion, hydrogen bonding, and water-binding properties, which allow it to form micro-
gel networks. The polymer inulin is highly effective in reducing or eliminating
serum separation in reconstituted suspensions and emulsions; still, it yielded the
greatest consistency. Using inulin as a stabilizer gives food items a smoother, more
uniform texture. Furthermore, inulin’s prebiotic properties may provide health ben-
ets. With all these advantages, inulin has shown to be an excellent substitute for
stabilizing a range of compositions in the pharmacological, culinary, and cosmetic
elds. This section summarizes the present state of research on inulin’s stabilizing
properties, with a focus on the elds’ future prospects for progress and possible uses.
Acknowledgments The authors acknowledge in particular ShriRam College of Pharmacy,
Banmore, Morena, Madhya Pradesh, India, for encouraging us and providing necessary facilities.
Funding There was no funding for this project from any source.
References
Anjuomo F, Abdella S, Youssef SH, Song Y, Garg S (2021) Inulin and its application in drug
delivery. Pharmaceuticals 14(9):855
Aguilar-Toalá JE, Garcia-Varela R, Garcia HS, Mata-Haro V, González-Córdova AF, Vallejo-
Cordoba B, Hernández-Mendoza A (2018) Postbiotics: an evolving term within the functional
foods eld. Trends Food Sci Technol 75:105–114
Al-Ghamdi NA, Raus RA, Yusof LM et al (2022) Recent advances in inulin-based materi-
als for controlled release applications. Molecules 27(7):2163. https://doi.org/10.3390/
molecules27072163
Audouy SAL, van der Schaaf G, Hinrichs WL, Frijlink HW, Wilschut J, Huckriede A (2011)
Development of a dried inuenza whole inactivated virus vaccine for pulmonary immuniza-
tion. Vaccine 29(26):4345–4352
Barba FJ, Esteve MJ, Frígola A (2010) Physicochemical and structural properties of bre-rich
powder: effects of inulin-type fructans in vegetable matrices. Food Chem 123(3):672–678
Bengoechea C, López-Castejón ML, Márquez S, Salinas V, Puppo C, Guerrero A (2019) Gelation
properties of calcium-inulin gels. Food Hydrocoll 97:105239
Carabin IG, Flamm WG (1999) Evaluation of safety of inulin and oligofructose as dietary ber.
Regul Toxicol Pharmacol 30(3):268–282
4 Inulin asStabilizer

88
Celińska E, Nicaud JM, Białas W (2021) Hydrolytic secretome engineering in Yarrowia lipolytica
for consolidated bioprocessing on polysaccharide resources: review on starch, cellulose, xylan,
and inulin. Appl Microbiol Biotechnol 105:975–989
Council of Europe (2020) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Delzenne NM, Cani PD (2005) A place for dietary bre in the management of the metabolic
syndrome. Curr Opin Clin Nutr Metab Care 8(6):636–640. https://doi.org/10.1097/01.
mco.0000171124.01302.5c
Delzenne NM, Neyrinck AM, Backhed F etal (2011) Targeting gut microbiota in obesity: effects
of prebiotics and probiotics. Nat Rev Endocrinol 7(11):639–646. https://doi.org/10.1038/
nrendo.2011.126
Eriksson HJC, Verweij WR, Poelstra K etal (2003) Investigations into the stabilisation of drugs by
sugar glasses: II- delivery of an inulin-stabilised alkaline phosphatase in the intestinal lumen
via the oral route. Int J Pharm 257(1–2):273–281
European Directorate for the Quality of Medicines & HealthCare (EDQM) (2020) Inulin. European
pharmacopoeia 10.0. EDQM, Strasbourg
Farzanmehr H, Abbasi S (2009) Effects of inulin and bulking agents on some physicochemical,
textural and sensory properties of milk chocolate. J Texture Stud 40(5):536–553
Fehlbaum S, Prudence K, Kieboom J et al (2018) In vitro fermentation of selected prebiotics
and their effects on the composition and activity of the adult gut microbiota. Int J Mol Sci
19(10):3097. https://doi.org/10.3390/ijms19103097
Ferreira-Lazarte A, Kachrimanidou V, Villamiel M et al (2020) Inulin hydrogels and nanocom-
posites for tissue engineering applications. J Mater Sci Mater Med 31(11):102. https://doi.
org/10.1007/s10856- 020- 06476- 2
Ferreira-Lazarte A, Kachrimanidou V, Villamiel M etal (2021) Inulin as a carrier of probiotics in
encapsulation systems: development and potential applications in food and pharmaceuticals.
Food Funct 12(4):1480–1498. https://doi.org/10.1039/d0fo03165a
Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M (2001) Inulin and oligofructose
as dietary ber: a review. C R Acad Sci III 322(1):1–42
Food and Agriculture Organization of the United Nations (FAO) (1999) Inulin and oligofructose
in food and feed. FAO, Rome
Franck A (2002) Technological functionality of inulin and oligofructose. Br J Nutr
87(S2):S287–S291
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introduc-
ing the concept of prebiotics. J Nutr 125(6):1401–1412. https://doi.org/10.1093/jn/125.6.1401
Kim WS, Cho CS, Hong L etal (2019) Oral delivery of probiotics using pH-sensitive phthalyl
inulin tablets. J Microbiol Biotechnol 29:200–208. https://doi.org/10.4014/jmb.1811.11021
Kolida S, Gibson GR (2007) Prebiotic capacity of inulin-type fructans. J Nutr 137(11):2503S–2506S
Kylli P, Mikkonen KS, Aura AM etal (2022) Effects of inulin addition on hair hydration and luster.
Int J Cosmet Sci 44(3):281–287. https://doi.org/10.1111/ics.12912
Lanjhiyana SK (2020) Polysaccharides based novel and controlled released multiparticulate
systems for colon-specic delivery: contemporary scenario and future prospects. Asian J
Pharm 14(4)
Linhardt RJ, Galliher PM, Cooney CL et al (2011 December 1) Nonionic polysaccharides.
U.S.Patent US20110293697A1
Loos HM, Rombouts I, Leclercq G etal (2022) Sustainable production of inulin: a comprehensive
review of extraction and processing technologies. Crit Rev Food Sci Nutr 62(17):4660–4676.
https://doi.org/10.1080/10408398.2021.1901650
López-Castejón ML, Bengoechea C, Espinosa S, Carrera C (2019) Characterization of prebiotic
emulsions stabilized by inulin and β-lactoglobulin. Food Hydrocoll 87:382–393
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WL (2015) Inulin, a exible oli-
gosaccharide I: review of its physicochemical characteristics. Carbohydr Polym 130:405–419
Morin-Crini N, Lichtfouse E, Torri G etal (2021) Applications of chicory and inulin in industry and
environmental sustainability. Environ Chem Lett 19(2):1085–1102. https://doi.org/10.1007/
s10311- 020- 01108- 5
B. S. R. Desu et al.

89
Niness KR (1999) Inulin and oligofructose: what are they? J Nutr 129(7):1402S–1406S
Pankaj S, Ashish D, Dheerendra R, Yogendra R, Ramakant JK, Kuldeep S (2015) Formulate and
evaluate orodispersible tablets of primaquine. Indo Am J Pharm Res 5(5):1625–1632
Pankaj S, Mukul T (2019) PH dependent release potential of natural polymers in sustained release
of ornidazole from colon targeted delivery system. Magnesium 10(10):10
Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with
decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr
89(6):1751–1759. https://doi.org/10.3945/ajcn.2009.27465
Peanparkdee M, Iwamoto S (2022) Inulin nanoparticles for enhanced solubility and stability of
poorly soluble drugs. Colloids Surf B Biointerfaces 209:112201. https://doi.org/10.1016/j.
colsurfb.2021.112201
Ramasamy T, Poudel BK, Ruttala H etal (2020) Encapsulation and controlled release of active
compounds using inulin-based delivery systems. Carbohydr Polym 245:116527. https://doi.
org/10.1016/j.carbpol.2020.116527
Ramasamy T, Poudel BK, Ruttala H et al (2021) Development of inulin-based biosensors
for biomedical applications. Biosens Bioelectron 176:112938. https://doi.org/10.1016/j.
bios.2020.112938
Roberfroid M, Gibson GR, Hoyles L etal (2010) Prebiotic effects: metabolic and health benets.
Br J Nutr 104(Suppl 2):S1–S63. https://doi.org/10.1017/S0007114510003363
Roberfroid MB (2005) Introducing inulin-type fructans. Br J Nutr 93(S1):S13–S25
Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr
137(11):2493S–2502S
Rowe RC, Sheskey PJ, Quinn ME (eds) (2012) Handbook of pharmaceutical excipients, 7th edn.
Pharmaceutical Press, London
Santana AA, dos Santos KA, da Silva KA etal (2020) Inuence of inulin addition on the properties
of topical formulations. Drug Dev Ind Pharm 46(6):980–987. https://doi.org/10.1080/0363904
5.2020.1758954
Sharma P (2021) Modication of human behavior due to coronavirus outbreak: a brief study on
current scenario. Asian J Pharm 15(3)
Sharma P (2022) Applications of statistical tools for optimization and development of smart drug
delivery system. In: Smart drug delivery. Intech Open, London, p183
Sharma P (2023) Nanostructured biomaterials in drug delivery: current trends and upcoming pos-
sibilities. In: Engineered biomaterials: synthesis and applications. Springer Nature, Singapore,
pp261–280
Sharma P, Bhargava S, Parashar D, Mangal A (2017) Formulation and evaluation of nanoparticles
containing cyclophosphamide. WJPR 7(1):785–798
Sharma P, Dasputre N, Jain V (2024) Nanomedicine: concepts, characteristics, and regulatory
challenges. In: Smart nanocarrier for effective drug delivery. CRC Press, pp1–16
Sharma P, Jain V, Jain S (2021) Fabrication, optimization and evaluation of chronotropic drug
delivery system of captopril. Int J Pharm Sci Res 12:2203–2210
Sharma P, Jain V, Tailang M (2022) Selection and role of polymers for designing of a drug carrier.
In: Drug carriers. IntechOpen. https://doi.org/10.5772/intechopen.103125
Sharma P, Jain V, Tailang M (2023) Advancement of nanocarrier-based engineering for specic
drug delivery for cancer therapy. In: Targeted cancer therapy in biomedical engineering.
Springer Nature, Singapore, pp465–486
Sharma P, Tailang M (2017) Opportunities and challenges to develop transdermal patch with nano-
carrier. WJPR 6(15):392–400
Sharma P, Tailang M (2020) Design, optimization and evaluation of buccal drug delivery system of
propranolol for hypertension treatment. Int J Pharm Sci Res 11(1):301–311
Sharma P, Tailang M (2022) Primaquine-loaded transdermal patch for treating malaria: design,
development, and characterization. Futur J Pharm Sci 8(1):43
Silva RF, Beerens J, Soltanizadeh N, Kadivar M, Steenkamp J, Duodu KG (2020) Rheological and
thermal properties of inulin-enriched wheat our dough and bread. LWT 123:109096
4 Inulin asStabilizer

90
Singh DP, Singh J, Boparai RK etal (2017) Isomalto-oligosaccharides, a prebiotic, functionally
augment green tea effects against high fat diet-induced metabolic alterations via preventing gut
dysbacteriosis in mice. Pharm Res 119:45–56
Slavin JL (2005) Dietary ber and body weight. Nutrition 21(3):411–418. https://doi.org/10.1016/j.
nut.2004.08.018
United States Pharmacopeia Convention (2018) USP 41-NF 36. United States Pharmacopeial
Convention, Rockville, MD
van Loo J, Coussement P, de Leenheer L etal (1995) On the presence of inulin and oligofructose
as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 35(6):525–552. https://doi.
org/10.1080/10408399509527704
Wada T, Sugatani J, Terada E, Saito H, Furukawa N (2003) Solubility and fermentation of dietary
ber inulin in the rat intestinal tract. J Nutr Sci Vitaminol 49(2):133–137
Zhang Y, Yang Y, Wang J etal (2021b) Inulin-based nanocarriers for efcient targeted deliv-
ery of anticancer drugs. Int J Biol Macromol 184:109–117. https://doi.org/10.1016/j.
ijbiomac.2021.06.131
Zhang Z, Tan S, Feng S et al (2021a) Inulin as a promising biomaterial for nanoparticle-based
pharmaceutical delivery systems. Int J Nanomedicine 16:4971–4984. https://doi.org/10.2147/
IJN.S310781
B. S. R. Desu et al.

91
5
Inulin asaCoating Agent
ShwetaMishra, AdarshSahu, S.Anakha,
andMayankChoubey
Abstract
Inulin, as a unique and exible structure, has been one of the most popular bio-
degradable polymers for the development of drug delivery systems due to its
stabilization and protective effects and organ-targeting ability, including
improved bioavailability, better cellular uptake, and sustained and controlled
release of drugs and biomolecules. Inulin belongs to the fructan group of poly-
saccharides and has recently gained attention as a potential coating material,
especially in studies of colon-targeted nanosized drug delivery systems, because
of its rapid water solubility, low friability, and stability against gastric and intes-
tinal enzymes. This chapter presents a comprehensive overview of the funda-
mentals and application of inulin as a coating agent for the delivery of therapeutic
agents. Furthermore, chemical behavior, challenges, and future perspectives
related to the use of inulin coatings for drug delivery purposes are discussed here.
Keywords
Inulin · Coating · Natural polymers · Polysaccharides · Drug delivery
S. Mishra (*)
SGT College of Pharmacy, SGT University, Gurugram, Haryana, India
A. Sahu
Amity Institute of Pharmacy, Amity University Rajasthan, Jaipur, Rajasthan, India
S. Anakha
KTN College of Pharmacy, Palakkad, Kerala, India
M. Choubey
Department of Mechanical engineering, Faculty of Engineering and Technology,
SGT University, Gurugram, Haryana, India

92
5.1 Introduction
Inulin is a fructan, a type of carbohydrate found primarily in plants of the Asteraceae
family. Fructans are composed of two compounds: inulin and oligofructose. Inulin
is a exible, high-molecular-weight fructan-type oligosaccharide found in diverse
array of plants. It has hydrophilic characteristics and contains dietary ber. It is
obtained from edible vegetables and fruits such as onion, garlic, leek, and banana.
Chicory (Cichorium intybus) and Jerusalem artichoke are the primary raw material
sources which is used in industrial production of inulin (Gupta etal. 2019; Mensink
etal. 2015). They are usually collected from different parts of more than 36,000
plant species, but the primary source is found to be the roots of Cichorium intybus
(chicory) (Gupta etal. 2019). Inulin is used in several industries, including food,
pharmaceuticals, cosmetics, and biotechnology. With their excellent nutritional and
technological benets, they have become part of our daily food intake for centuries
(Shoaib etal. 2016). For pharmaceutical formulations, chemically modied inulin
is being investigated. Natural or hydrophobically modied inulin nanoparticles can
be synthesized by self-assembly process and used in many biological processes as
nanostructured prebiotics. On the other hand, inulin alone or in combination with
other biopolymers can be utilized as a coating material for the encapsulation of
bioactive chemicals and the development of their delivery systems. Inulin coating
may improve the physicochemical and biological properties of bioactive com-
pounds, allowing for regulated release as well as protecting the bioactive compo-
nent from adverse environmental conditions.
Inulin-coated bioactive compounds have a variety of applications in medical
elds, including immunological regulation, prebiotic action, blood sugar regulation,
lipid content regulation, anticancer activity, and antioxidant activity. It can also be
utilized as a thickener, fat replacer, water-retaining agent, and sweetener in the food
industry (Wan et al. 2020). Additionally, the non-metabolizable, nontoxic, and
freely ltered nature of inulin makes it an ideal compound for assessing the glo-
merular ltration rate (GFR). There are some drugs that lack efciency due to poor
biological and chemical stability and a lack of organ tropism, which can be cor-
rected by combining the appropriate agent with inulin (van Bekkum etal. 1994).
Furthermore, inulin was approved by the USFDA in 1992 as a safe and effective
nutritional supplement for babies, and in 2018 the agency reiterated that inulin has
increased the nutritional content of a number of functional food products (Giri
etal. 2021).
Many several studies revealed that several materials, like polysaccharides, gly-
cols, etc., have been used as coatings for liposomes due to their low or nontoxicity,
biocompatibility, and neutral organoleptic properties, while inulin is a polysaccha-
ride that can be used for the encapsulation of antioxidants and many other bioactive
molecules (Román-Aguirre etal. 2020).
When we investigate the conventional drug delivery system, which consists of
immediate-release tablets, capsules, and other formulations that deliver drugs to the
site, it has a lot of disadvantages like frequent dosing, poor patient compliance, poor
bioavailability, drug loss through rst-pass metabolism, and even gastric irritancy in
S. Mishra et al.

93
some cases (Fig.5.1). All these can be overcome by the application of a controlled
drug delivery system that delivers drugs at a specic site at a predetermined rate
(Pandey etal. 2019). Controlled-release drug delivery systems are introduced to
enhance drug therapy by assisting the drug to cross physiological barriers and
shielding the drug from premature elimination. These systems are composed of bio-
compatible materials that are sensitive to various stimuli and can release the active
molecule at the right place, among which the most productive one is polymers
(Siegel and Rathbone 2011; Aghabegi Moghanjoughi etal. 2016).
These drug delivery systems comprise mostly drug-encapsulated devices that
release the therapeutic agents at a controlled rate for a long period of time at the
specic targeted site (Aghabegi Moghanjoughi etal. 2016). Depending upon the
characteristics of the drug, a single or combination of polymers can be used that
are mixed with the specic drug, and the release of the drug slows down in the
medium through mechanisms involving diffusion, dissolution, or a combination
of diffusion- dissolution or erosion-based controlled mechanisms. These polymers
can be classied into many types based on the molecular force, source, type of
polymerization, structure, and so on. Depending on the source, it is a natural,
semisynthetic, or synthetic polymer type, all having their own advantages and
disadvantages.
The synthetic polymers, when incorporated for controlled drug delivery, had
many drawbacks, such as instability problems, expensive chemical modication,
poor receptor targeting properties, weak mechanical properties, biodegradation,
excretion, etc. One solution to tackle this issue was found to be using nontoxic and
biodegradable natural polysaccharides instead, since they have optimum receptor
targeting and stealth properties to produce better patient outcomes with minimized
side effects. Properties like molecular exibility, ability to stabilize proteins, self-
assembled structures, ease of chemical modication, and immune modulation pro-
vide uniqueness to inulin, which helps to utilize it as a drug delivery scaffold and
Fig. 5.1 Advantages of inulin-based drug delivery system
5 Inulin asaCoating Agent

94
biomaterial. The unique properties of inulin help in its exploitation for many phar-
maceutical applications (Anjuomo etal. 2021). Given the extensive research on
the various applications of inulin, it is crucial to thoroughly investigate its optimal
modication for use as both a nutrition and drug delivery system. This will pave the
way for future studies and enable us to fully harness its potential in sustainable
development (Teferra 2021).
5.2 Sources Isolation ofInulin
There are two phases involved in the production of inulin. The rst step is the
extraction phase, which is followed by a rst purication step that results in a semi-
rened syrup. The second step is the rening phase, which leads to a commercial
nal product that is signicantly pure more than 99.5%. The rst phase of the
chicory process, which is like the sugar beet process, produces commercial inulin
(Qin etal. 2023). There are several natural sources of inulin, such as chicory roots,
Jerusalem artichoke, dahlia tubers, yacon, asparagus, leek, onion, bacon, wheat,
and garlic (Zhang etal. 2022). Chicory root is the main commercial source of inu-
lin. Cichorium intybus (common name: chicory) is a perennial herbaceous plant
belonging to the Asteraceae family. Dahlia and Jerusalem artichoke are the other
important sources for the industrial production of inulin in temperate areas. The
isolation process of inulin (Redondo-Cuenca etal. 2021) is schematic represented
in Fig.5.2.
Fig. 5.2 Steps of isolation process of inulin
S. Mishra et al.

95
5.3 Chemistry ofInulin
Inulins are naturally occurring polysaccharides containing 2–60 fructose units.
They are a chemically linear polydisperse carbohydrate with β-(2-1)--fructosyl
fructose linkages between the fructose units and α-1, β-2-linked glucose molecules
as the terminal molecule (Roberfroid 2005; Schaafsma and Slavin 2015). Their rst
monomer can be either β--glucopyranosyl or β--fructopyranosyl residue
(Schaafsma and Slavin 2015). Inulin is a general chemical formula that is expressed
as C
6n
H
10n+2
O
5n+1
, where “n” indicates the number of repeating units (fructose mol-
ecules) that are present in the polymer chain. In most instances, inulins are a poly-
disperse mixture of fructan chains, with a chain length (degree of polymerization
(DP)) dispersion dependent on the source. Inulin’s fructose units and β-conguration
of anomeric carbon form β-(2-1) -fructosyl fructose bonds, making it indigestible
on the human small intestine. On the other hand, the microora of the intestinal
system makes it possible for it to ferment outside of the large intestine. Inulin-type
fructan is composed of linear (2→1)-linked β--fructosyl units connected to the
fructosyl moiety of sucrose (Judprasong etal. 2011). Chicory inulin has fructose
units ranging from 2 to 60, indicating a mix of oligomers and polymers. The DP
(degree of polymerization) and branches have an effect on the functionality of the
inulin. Plant inulins have relatively low DP (maximally <200) which depends on
plant species, climatic conditions, and the plant’s physical condition. Inulin present
in bacteria has a very high DP, ranging from 10,000 to above 100,000; furthermore,
a bacterial inulin is 15% more branched than the plant inulin.
5.4 Physicochemical Features ofInulin
As a unique food ingredient, inulin has many important health benets and also has
some useful industrial properties that make it useful in many food uses. It has been
reported that inulin is moderately water-soluble and has a 3D microcrystalline gel
network with a creamy structure that is formed at high temperatures (Schaafsma and
Slavin 2015). On removal of one monomer unit of inulin molecules, its sweetness is
decreased, and the gel-forming capabilities can be enhanced. Chicory inulin is a
white powder with small, translucent particles. The inulin has a neutral avor, and
it does not leave an aftertaste. Regular chicory inulin has a sweetness level of
approximately 10% when compared to sucrose, even though long-chain inulin is not
sweet. Inulin behaves similarly to bulking substances, and, together with high quan-
tities of articial sweeteners like aspartame and acesulfame K, it offers an excellent
tongue feel with a small after taste. Chicory inulin is considerably dissolved in
water (almost 10% at 25°C), allowing for its inclusion in an aqueous media without
precipitation. Inulin solubilizes in hot water (temperature at 50–100°C) (Roberfroid
2005). Chicory inulin solutions have a comparatively low viscosity: for a 5% solu-
tion, 1.65mPa.s at 10°C, and for a 30% solution, 100mPa.s. For hydrolysis of
inulin, some parameters such as low pH, high temperature, less dry-substance envi-
ronments, etc., are required. Furthermore, in an acidic environment, β-(2-1) bonds
5 Inulin asaCoating Agent
Соседние файлы в папке Библиотека им академика М.И. Перельмана
